Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological impact and therapeutic potential of a novel camptothecin derivative (FLQY2) in pancreatic cancer through inactivation of the PDK1/AKT/mTOR pathway. | Bioorg Chem | 2024 | 38735265 | PubTator, text mining | PubMed |
| A human papillomavirus 16 E2-TopBP1 dependent SIRT1-p300 acetylation switch regulates mitotic viral and human protein levels and activates the DNA damage response. | mBio | 2024 | 38722185 | PubTator, text mining | PubMed |
| Protocol for mapping physiological DSBs using in-suspension break labeling in situ and sequencing. | STAR Protoc | 2024 | 38717906 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. | Clin Cancer Res | 2024 | 38709212 | PubTator, text mining | PubMed |
| Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies. | Bioorg Chem | 2024 | 38696845 | PubTator, text mining | PubMed |
| R-loop and diseases: the cell cycle matters. | Mol Cancer | 2024 | 38678239 | PubTator, text mining | PubMed |
| Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma. | J Photochem Photobiol B | 2024 | 38663337 | PubTator, text mining | PubMed |
| Design of Evodiamine-Glucose Conjugates with Improved In Vivo Antitumor Activity. | J Med Chem | 2024 | 38646851 | PubTator, text mining | PubMed |
| Chemoinformatics and machine learning techniques to identify novel inhibitors of the lemur tyrosine kinase-3 receptor involved in breast cancer. | Front Mol Biosci | 2024 | 38638686 | PubTator, text mining | PubMed |
| Transcriptomic analysis of HEK293A cells with a CRISPR/Cas9-mediated TDP1 knockout. | Biochim Biophys Acta Gen Subj | 2024 | 38621596 | PubTator, text mining | PubMed |
| Prediction of digital transformation of manufacturing industry based on interpretable machine learning. | PLoS One | 2024 | 38551908 | PubTator, text mining | PubMed |
| Research on a Cross-Domain Few-Shot Adaptive Classification Algorithm Based on Knowledge Distillation Technology. | Sensors (Basel) | 2024 | 38544201 | PubTator, text mining | PubMed |
| Predicting nuclear G-quadruplex RNA-binding proteins with roles in transcription and phase separation. | Nat Commun | 2024 | 38519458 | PubTator, text mining | PubMed |
| Clinical and molecular cytogenetic studies of five new patients with 20q11q12 deletion and review of the literature: Proposition of two critical regions. | Am J Med Genet A | 2024 | 38511524 | PubTator, text mining | PubMed |
| Style classification of media painting images by integrating ResNet and attention mechanism. | Heliyon | 2024 | 38496868 | PubTator, text mining | PubMed |
| Deletions initiated by the vaccinia virus TopIB protein in yeast. | DNA Repair (Amst) | 2024 | 38484460 | PubTator, text mining | PubMed |
| The Novel ATR Inhibitor M1774 Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs. | Mol Cancer Ther | 2024 | 38466804 | PubTator, text mining | PubMed |
| Unleashing the Potential of Camptothecin: Exploring Innovative Strategies for Structural Modification and Therapeutic Advancements. | J Med Chem | 2024 | 38421819 | PubTator, text mining | PubMed |
| BioLORD-2023: semantic textual representations fusing large language models and clinical knowledge graph insights. | J Am Med Inform Assoc | 2024 | 38412333 | PubTator, text mining | PubMed |
| Color constancy in real-world settings. | J Vis | 2024 | 38411957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=17